Skip to content

Roche Reagent for Ethanol

by Roche Diagnostic Systems, Inc. 510(k)

Active United States

510(k) K913125

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK913125 Date12 Aug 1991ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DIC
Device Class
Class II
Regulation
21 CFR Part 862.3040
Advisory Committee
Clinical Toxicology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a specific reagent for ethanol using the enzyme method (alcohol dehydrogenase), classified under the nomenclature for in vitro diagnostic reagents. It is designed for quantitative measurement of ethanol concentrations in human serum, plasma, and urine samples.

The reagent is supplied for use on Roche/Hitachi cobas c systems, including the cobas c 503 analyzer, and is intended for clinical toxicology applications. It is a single-use diagnostic reagent, with regulatory clearance under FDA 510(k) (K913125) as substantially equivalent to a predicate device. Storage and handling follow standard in vitro diagnostic reagent protocols.

Other devices from Roche Diagnostic Systems, Inc.

See all devices from Roche Diagnostic Systems, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of biological samples can this reagent measure ethanol in, and how is it used clinically?

    This reagent is designed for quantitative measurement of ethanol concentrations specifically in human serum, plasma, and urine samples. It uses the enzyme method with alcohol dehydrogenase, making it suitable for clinical toxicology applications, such as assessing alcohol intoxication or monitoring ethanol levels in patients.

  • Is this reagent compatible with any specific laboratory equipment, and how is it supplied?

    The reagent is exclusively intended for use on Roche/Hitachi cobas c systems, including the cobas c 503 analyzer. It is supplied as a single-use diagnostic reagent, adhering to standard in vitro diagnostic reagent protocols for storage and handling.

  • How should this reagent be stored, and is it intended for single-use only?

    While the exact storage instructions are not detailed here, this reagent follows standard in vitro diagnostic reagent protocols, which typically require refrigeration and protection from light. Yes, it is explicitly designed for single-use only, ensuring accuracy and preventing cross-contamination.

  • What regulatory pathway was followed for this reagent’s clearance, and what does that mean for its use?

    This reagent received FDA clearance under a 510(k) submission (K913125), classified as substantially equivalent to a predicate device. This means it was reviewed for safety and performance against an existing, cleared device and is authorized for clinical toxicology use, specifically for measuring ethanol in serum, plasma, and urine.